SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-098423
Filing Date
2023-04-12
Accepted
2023-04-12 06:54:59
Documents
14
Period of Report
2023-04-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d442377d8k.htm   iXBRL 8-K 31251
2 EX-99.1 d442377dex991.htm EX-99.1 13799
6 GRAPHIC g442377g0412101450878.jpg GRAPHIC 2564
  Complete submission text file 0001193125-23-098423.txt   184404

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20230412.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20230412_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20230412_pre.xml EX-101.PRE 12156
8 EXTRACTED XBRL INSTANCE DOCUMENT d442377d8k_htm.xml XML 3584
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 23814597
SIC: 2834 Pharmaceutical Preparations